The Bioavailability Enhancement Services Market is projected to grow at an annualized rate of 11.12% till 2035, according to a market research report by Roots Analysis

Bioavailability is known to form an integral part of the drug pharmacokinetics. As a result, over the last couple of years, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. Further, a study conducted on terminated drug development projects revealed that majority of the candidates fail in early phases. The study further highlighted that the aforementioned drug failures can primarily be attributed to the problems associated with pharmacokinetic profiles, ADME (distribution, metabolism, absorption and excretion) properties and toxicity-related concerns. At present, more than 40% of the marketed drugs are believed to possess low bioavailability, while around 90% of all New Chemical Entities (NCEs), which are being evaluated in pre-clinical and clinical stages of development, exhibit solubility / permeability related issues. Consequently, recent years have seen a rise in drug developers evaluating various re-formulation strategies to improve…

Bioavailability is known to form an integral part of the drug pharmacokinetics. As a result, over the last couple of years, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. Further, a study conducted on terminated drug development projects revealed that majority of the candidates fail in early phases. The study further highlighted that the aforementioned drug failures can primarily be attributed to the problems associated with pharmacokinetic profiles, ADME (distribution, metabolism, absorption and excretion) properties and toxicity-related concerns. At present, more than 40% of the marketed drugs are believed to possess low bioavailability, while around 90% of all New Chemical Entities (NCEs), which are being evaluated in pre-clinical and clinical stages of development, exhibit solubility / permeability related issues. Consequently, recent years have seen a rise in drug developers evaluating various re-formulation strategies to improve the bioavailability of existing drugs / drug candidates. In fact, an increasing number of drug candidates have been granted approval via the 505(b)(2) pathway; the aforementioned pathway is used to gain approval for novel formulations consisting of previously approved active pharmaceutical ingredient (API). Additionally, given the shifting focus of drug developers towards development of lipophilic drug compounds, the industry is actively undertaking efforts to identify various bioavailability enhancement techniques, in order to mitigate the challenge of low bioavailability and stability.

To order this 270+ page report, which features 175+ figures and 170+ tables, please visit 
https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html

Key Market Insights

For more information, please visit  https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html

The financial opportunity within the bioavailability enhancement services market has been analyzed across the following segments:

The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), recent developments (including partnerships and collaborations) and an informed future outlook.

Key Questions Answered

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape: Bioavailability Enhancement Service Providers

5. Market Landscape: Bioavailability Enhancement Technology Providers

6. Key Insights

7. Company Profiles

8. Company Benchmark Analysis

9. Partnerships and Collaborations

10. Publication Analysis

11. Patent Analysis

12. Clinical Trial Analysis

13. Technology Evaluation Framework

14. Demand Analysis

15. Market Forecast and Opportunity Analysis

16. Conclusion

17. Appendix 1: List of Companies 

18. Appendix 2: Tabulated Data

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html
or email sales@rootsanalysis.com 

You may also be interested in the following titles:

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
gaurav.chaudhary@rootsanalysis.com

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/the-bioavailability-enhancement-services-market-is-projected-to-grow-at-an-annualized-rate-of-11-12-till-2035--according-to-a-market-research-report-by-roots-analysis-301924932.html